The discovery of Paxlovid- the journey of the Pfizer SARS2-Covid 19 drug
Dr Dafydd Owen, Senior Director Medicinal Chemistry, Pfizer, Cambridge Massachusetts will talk about: “The discovery of Paxlovid- the journey of the Pfizer SARS2-Covid 19 drug. ”
Dr Owen was the team leader at Pfizer to develop the oral inhibitor Paxlovid, targeting the SARS2-Covid 19 protease. This discovery was one of the milestones to mitigate the recent COVID19 pandemic.
Date:
15 September 2023, 12:00
Venue:
Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details:
Lecture theatre
Speaker:
Dr Dafydd Owen (Pfizer, Cambridge Massachusetts)
Organising department:
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Organiser:
Udo Oppermann (University of Oxford)
Organiser contact email address:
james.dunford@ndorms.ox.ac.uk
Host:
Udo Oppermann (NDORMS, University of Oxford)
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Josie Eade
